Data were compared the Kruskal-Wallis test. P-values were adjusted for multiple measurements as described in Methods. 
Supplemental

Supplemental File Legends
File S1. Comparing the cytokine profiles of healthy subjects and TB, DM and TBDM patients.
Comparisons between the 4 groups were performed using limma R package. See "README" tab for details.
File S2. Differential expression gene and pathway enrichment analyses.
The "DEGs" tab shows the differentially expressed genes between each pair of classes (out of 4 in total: healthy subjects and TB, DM and TBDM patients). Comparisons between the 4 groups were performed using limma R package. The "IPA_upstream" tab shows all upstream regulators with p-value < 0.01 in at least one list of DEGs. The "IPA_CanonicalPathway" tab shows canonical pathways with p-value < 0.01 in at least one list of DEGs. See "README" tab for details.
File S3. Related and unrelated pathways linked to diabetic complications activated in patients with comorbid TB.
Single sample Gene Set Enrichment Analysis (ssGSEA) was performed for each patient using the genes ranked by their MDP score and Reactome pathways as gene sets (P < 0.01, 1,000 permutations). The "ssGSEA" tab shows the sum of Normalized Enrichment Score (NES) for all patients from each one of the 4 groups (healthy, TB, DM, TBDM). Only NES with nominal p-value < 0.01 were used. Reactome pathways with less than 15 genes were discarded. Reactome pathways not significantly enriched in any patient were discarded.
File S4. Integrative analysis applied to identify the potential drivers of the plasma cytokine changes in TBDM comorbidity.
The "Cytokine_vs_gene" tab shows the Pearson correlation matrix between cytokine levels (rows) and gene expression (columns). The "Pathway_vs_gene" tab shows the Spearman correlation matrix between Reactome pathway activity (rows) and gene expression (columns).
